AI assistant
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013
Nov 27, 2013
30339_dirs_2013-11-27_1dc14c4f-e411-4905-bf7a-56e9a8cb3129.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-11-26
Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-26 | Common Stock | S | 15000.0000 | $48.6358 | Disposed | 990801.3732 | Direct |
| 2013-11-26 | Common Stock | S | 20000.0000 | $48.5737 | Disposed | 970801.3732 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2683.4400 | Indirect |
| Common Stock | 41713.5742 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold on the same date in multiple transactions at prices ranging from $48.50 to $48.965, inclusive. The reporting person undertakes to provide to issuer, any security holder of issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the numer of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2: The price reported in column 4 is a weighted average price. These shares were sold on the same date in multiple transactions at prices ranging from $48.41 to $48.73.